Birds's Eye
Technicals
MovingAverage
Candlestick
PivotPoint
Fin Statements
Beta&Vols
Tech ChartsFundamental Analysis of Shilpa Medicare - Growth / Value Index
SHILPAMED - Valuation Highlights
Valuation Analysis
Tsr Value Index - Poor Score of 20.83
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Price to Earning | 62.26 | 82.51 | -34.25 % | ||
| Price to Book | 3.10 | 2.72 | 23.15 % | 1.38 | |
| Price to Sales | 5.26 | 5.02 | 44.60 % | ||
| Enterprise Value to EBITDA Multiple | 22.49 | 18.68 % |
SHILPAMED - Profitability Highlights
Profitability Analysis
Piotroski F Score - Excellent Value of 8.0
Excellent QoQ /QoQ FY EPS growth
Annual Net Profit in last 3 years is trending up
Company's Net Profit is increasing for last 5 Quarters
Company's Profit Before Tax is increasing for last 5 Quarters
EBITDA is continuously increasing for last 3 Years
Steady Growth in EPS for last four quarters
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Return On Equity | 4.96 | 3.30 | 87.30 % | 1.98 | |
| Return On Asset | 3.48 | 2.36 | 129.52 % | 1.42 | |
| Net Profit Margin | 8.45 | 6.09 | 119.91 % | 14.59 | |
| Operating Profit Margin | 40.66 | 9.99 | 156.75 % | 28.51 | |
| EBITDA Margin | 24.98 | 24.26 | 7.96 % | 30.26 |
Highlights
| Market Cap | 69011.04 M |
| Enterprise Value | 74616.38 M |
| Price/Book TTM | 3.10 |
| Outstanding Share | 195581 K |
| Float/ Outstanding Share | 48.05% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 2.83 |
| Peter Lynch Ratio | 1.91 |
| Piotroski F Score | 8.00 |
| Altman Z Score | 5.58 |
| Sloan Ratio | 0.0439 |
| Peter Lynch Fair Value | 32.39 |
SHILPAMED - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 119.91%
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Very Poor Score of 14.13
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1315.39 (Cr) | 11.71 % | 2.83 % |
| Gross Profit | 918.30 (Cr) | 146.99 % | 6.86 % |
| EBITDA | 328.61 (Cr) | 20.60 % | 66.12 % |
| Net Profit | 111.12 (Cr) | 145.65 % | 223.16 % |
| EPS | 5.67 | 119.07 % | NA |
SHILPAMED - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 67.19
Altman Z Score of 5.58 suggests good Stability
Debt to equity ratio has decreased and is lowest in last five years
Company financial liquidity has improved
Company is unable to generate enough free cash to support the business.
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|
| Debt to Equity Ratio | 0.247 | -52.23 % | 0.248 | |
| Cash Ratio | 0.0423 | -3.64 % | ||
| Quick Ratio | 0.946 | 23.30 % | 0.946 | |
| Shareholders Equity | 71.65 | 22.54 % | ||
| Debt to EBITDA | 1.88 | -48.05 % |
Historical Valuation Ratios of Shilpa Medicare
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Shilpa Medicare
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Shilpa Medicare
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Shilpa Medicare
Historical Solvency Ratios
Loading ...